Quality of life after ablative 5-fraction radiation therapy from the phase II SMART pancreas trial

被引：0

作者：

Chuong, M. ^{[1
]}

Parikh, P. ^{[2
]}

Low, D. ^{[3
]}

Kim, J. ^{[2
]}

Mittauer, K. ^{[1
]}

Bassetti, M. ^{[4
]}

Glide-Hurst, C. ^{[4
]}

Raldow, A. ^{[3
]}

Yang, Y. ^{[3
]}

Portelance, L. ^{[5
]}

Zaki, B. ^{[6
]}

Kim, H. ^{[7
]}

Mancias, J. ^{[8
]}

Ng, J. ^{[9
]}

Pfeffer, R. ^{[10
]}

Mueller, A. ^{[11
]}

Kelly, P. ^{[12
]}

Boldrini, L. ^{[13
]}

Fuss, M. ^{[14
]}

Lee, P. ^{[15
]}

机构：

[1] Miami Canc Inst, Radiat Oncol, Miami, FL USA

[2] Henry Ford Hlth Canc, Radiat Oncol, Detroit, MI USA

[3] UCLA, Radiat Oncol, Los Angeles, CA USA

[4] Univ Wisconsin, Radiat Oncol, Madison, WI USA

[5] Univ Miami, Radiat Oncol, Miami, FL USA

[6] Dartmouth Hitchcock Med Ctr, Radiat Oncol, Lebanon, NH USA

[7] Washington Univ, Radiat Oncol, Sch Med St Louis, St Louis, MO USA

[8] Dana Farber Canc Inst, Radiat Oncol, Boston, MA USA

[9] Weill Cornell Med, Radiat Oncol, Sandra & Edward Meyer Canc Ctr, New York, NY USA

[10] Assuta Med Ctr, Radiat Oncol, Tel Aviv, Israel

[11] Thomas Jefferson Univ, Radiat Oncol, Philadelphia, PA USA

[12] Orlando Hlth Canc Inst, Radiat Oncol, Orlando, FL USA

[13] Fdn Policlin Univ A Gemelli IRCCS, Radiat Oncol, Rome, Italy

[14] ViewRay Inc, Radiat Oncol, Denver, CO USA

[15] City Hope Natl Med Ctr, Radiat Oncol, Los Angeles, CA USA

来源：

RADIOTHERAPY AND ONCOLOGY | 2023年 / 182卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

OC-0099

引用

页码：S61 / S61

页数：1

共 50 条

[1] Quality of Life after Ablative 5-Fraction Radiation Therapy from the Phase 2 SMART Pancreas Trial
Chuong, M. D.
Parikh, P. J.
Low, D.
Kim, J.
Mittauer, K. E.
Bassetti, M. F.
Glide-Hurst, C.
Raldow, A.
Yang, Y.
Portelance, L.
Zaki, B.
Kim, H.
Mancias, J. D.
Ng, J.
Pfeffer, R. M.
Mueller, A.
Kelly, P.
Boldrini, L.
Fuss, M.
Lee, P.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : S174 - S175
[2] Causes of Death Among Inoperable Pancreas Cancer Patients Receiving Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided Adaptive Radiation Therapy (SMART)
Chuong, Michael
Herrera, Roberto
Hall, Matthew
Kotecha, Rupesh
Ucar, Antonio
De Zarraga, Fernando
Aparo, Santiago
Joseph, Sarah
Mittauer, Kathryn
Gutierrez, Alonso
Alvarez, Diane
Romaguera, Tino
McCulloch, James
Asbun, Horacio
Jimenez, Ramon
Kaiser, Adeel
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2022, 45 (09): : S29 - S29
[3] Establishing the Aortic Maximum Tolerated Dose (MTD) for Ablative 5-Fraction Stereotactic MR-Guided Adaptive Radiation Therapy (SMART)
Mittauer, K. E.
Herera, R.
Romaguera, T.
Alvarez, D.
Mehta, M. P.
Gutierrez, A.
Chuong, M. D.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E555 - E555
[4] Lymphopenia and spleen dose for inoperable pancreatic cancer patients receiving ablative 5-fraction radiation therapy
Chuong, Michael D.
Herrera, Roberto
Carvallo, Nicolas
Rubens, Muni
Kotecha, Rupesh
Hall, Matthew D.
Mittauer, Kathryn E.
Bassiri-Gharb, Nema
Gutierrez, Alonso N.
Kaiser, Adeel
CANCER RESEARCH, 2024, 84 (02)
[5] Dose Escalation of 5-Fraction Radiation Therapy for Prostate Cancer: Quality of Life Comparison of 2 Prospective Trials
Quon, H. C.
Loblaw, D. A.
Cheung, P.
Tang, C. I.
Pang, G.
Morton, G.
Mamedov, A.
D'Alimonte, L.
Deabreu, A.
Tirona, R.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S148 - S149
[6] Causes of Death Among Patients With Initially Inoperable Pancreas Cancer After Induction Chemotherapy and Ablative 5-fraction Stereotactic Magnetic Resonance Image Guided Adaptive Radiation Therapy
Chuong, Michael D.
Herrera, Roberto
Ucar, Antonio
Aparo, Santiago
De Zarraga, Fernando
Asbun, Horacio
Jimenez, Ramon
Asbun, Domenech
Narayanan, Govindarajan
Joseph, Sarah
Kotecha, Rupesh
Hall, Matthew D.
Mittauer, Kathryn M.
Alvarez, Diane
McCulloch, James
Romaguera, Tino
Gutierrez, Alonso
Kaiser, Adeel
ADVANCES IN RADIATION ONCOLOGY, 2023, 8 (01)
[7] Stereotactic body radiation therapy as an emerging ablative therapy for recurrent gynecologic cancer: Early disease and quality of life outcomes from a phase II trial
Mantz, C.
Abu Shahin, F.
Grendys, E.
Orr, J.
GYNECOLOGIC ONCOLOGY, 2012, 125 : S126 - S126
[8] Lymphopenia and spleen dose for patients with inoperable pancreatic cancer receiving ablative 5-fraction radiation therapy.
Chuong, Michael David
Herrera, Roberto
Carvallo, Nicolas
Rubens, Muni B.
Kotecha, Rupesh
Hall, Matthew
Mittauer, Kathryn
Bassiri-Gharb, Nema
Gutierrez, Alonso
Kaiser, Adeel
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 686 - 686
[9] Is 5 the New 25? Long-Term Oncologic Outcomes From a Phase II, Prospective, 5-Fraction Preoperative Radiation Therapy Trial in Patients With Localized Soft Tissue Sarcoma
Bedi, Meena
Singh, Reena
Charlson, John A.
Kelly, Tracy
Johnstone, Candice
Wooldridge, Adam
Hackbarth, Donald A.
Moore, Nicole
Neilson, John C.
King, David M.
ADVANCES IN RADIATION ONCOLOGY, 2022, 7 (03)
[10] Patterns of Locoregional Failure After Ablative 5-Fraction Stereotactic MR-Guided on-Table Adaptive Radiation Therapy for Pancreatic Cancer
Chuong, M. D.
McAllister, N.
Carvallo, N.
Chundru, S.
Herrera, R.
Kaiser, A.
Hall, M. D.
Kotecha, R.
Mittauer, K. E.
Alvarez, D.
McCulloch, J.
Bassiri-Gharb, N.
Gutierrez, A.
Extein, J.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : S14 - S15

← 1 2 3 4 5 →